Member Exclusive News

Synthetic peptide to inhibit early stages of amyloid beta aggregation?

New research suggests that it is not amyloid beta plaques, but smaller oligomers that are the main culprit behind Alzheimer’s disease. Further, novel synthetic peptides have been developed which can successfully inhibit the aggregation of these toxic systems.

Apr 16, 2019

Please sign in or register for FREE

No comments yet.